The healthcare industry is changing. There is an increased demand to offer health monitoring solutions that are not only less expensive but also more efficient and provide better care. In short, the healthcare industry is joining
Onitor Track from Cloudtag Inc (LON:CTAG) is a unique, dual-position wearable that helps you lose the weight you want in the time you want to do it. Our intelligent design lets you reach your target weight
Here is another wearable device that can help you lose weight and get fit. Onitor Track is a weight loss wearable and program that lets you monitor your heart rate and get more active. The Track
It combines a dual-position wearable with a personalized weight loss and nutrition program delivered to ensure the user meets their weight loss target. Onitor Track from Cloudtag Inc (LON:CTAG) is the newly announced biometric, data-driven program designed
There are currently more than 20 million smart watches and more than 50 million fitness trackers sold in the market. This rise of wearable technology is just the beginning for more advanced wearables in the future.
Trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 16/12/2016 7:30am, an announcement having been made. ORDINARY SHARES OF 0.1P EACH, FULLY PAID
Commenting on the announcement, Amit Ben-Haim, CEO of CloudTag plc LON:CTAG said: “Having spent the last four months working closely with CITIES developing our go-to-market strategy with our respective executive teams, I am confident we have
CloudTag (CTAG:LN), the company that brings personal monitoring to the wellbeing, fitness and digital health markets has told DirectorsTalk that it has posted a circular to shareholders convening Extraordinary General Meeting of the Company to be
CloudTag (CTAG:LN), has told DirectorsTalk it has made the appointment of Yuval Lange as chief business development officer. Further to the Operational Updates of the 16 June 2016 and 12 September 2016, the Company continues to build
CloudTag (CTAG:LN), the company that brings personal monitoring to the weight loss, wellbeing, fitness and digital health markets has given DirectorsTalk an operational update and a placing to raise GBP500,000 net of expenses. 2016 has, to
CloudTag (CTAG:LN), the company that brings personal monitoring to wellbeing, fitness and digital health markets notes the recent increase in the Company’s share price. The Company continues to actively progress its business strategy of commercialising its
IBM Watson Health announced that its Watson for Oncology program, trained at Memorial Sloan Kettering Hospital, will be rolled out to 21 hospitals throughout China. The initial 21-hospital introduction is the beginning of a multi-year partnership through
Apple has reportedly acquired health data startup Gliimpse, a company that collects and combines disparate threads of personal health info. Fast Company reports that the acquisition went down earlier this year, but there has yet to
CloudTag (CTAG:LN), the company that brings personal monitoring to the wellbeing, fitness and digital health markets, Has told DirectorsTalk that it has raised GBP580,000 through the issue of 10,000,000 new ordinary shares (“Shares”) at a price
The Internet of Things (IoT) is expected to change dramatically in 2017, mainly with wearable technology, improved consumer experiences, and digital marketing. Brands need to implement changes to remain competitive in their respective industries. Below are
CloudTag’s Amit Ben-Haim discusses their US deal with CITIES in this exclusive interview with DirectorsTalk
Cloudtag Inc (LON:CTAG) CEO Amit Ben-Haim talks to DirectorsTalk about the US deal with CITIES. Amit talks about the commercial strategy for the US launch with CITIES and the impact the US will have for the
Commenting on the announcement, Amit Ben-Haim, CEO of CloudTag LON:CTAG said: “The UK, Europe and the US are the key target markets for the retailing of our first product. We are delighted to announce this agreement
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.